Interleukin 16 
Interleukin 16 (IL-16), originally identified in supernatants of mitogen-activated peripheral blood mononuclear cells (PBMCs) (1) , is synthesized as a large 67-kDa precursor protein (2) (3) (4) . This pro-IL-16 is almost exclusively expressed in lymphatic tissues (4) and contains three postsynaptic density protein, disc-large, zonulin-1 (PDZ) domains, i.e., modules involved in protein-protein interactions (5, 6) . The maturation of pro-IL-16 appears to be mediated by caspase 3 leading to the bioactive IL-16, which consists of the C-terminal 121 amino acids of the precursor (4, 7) . Activated CD8 ϩ and CD4 ϩ T cells synthesize identical levels of IL-16 transcripts, but mature IL-16 is predominantly secreted by CD8 ϩ T lymphocytes in response to antigens, histamine, or serotonin (8, 9) . In addition, human mast cells also synthesize pro-IL-16, and treatment with anaphylatoxin, C5a, or 12-O-tetradecanoylphorbol-13-acetate (TPA) increases the IL-16 mRNA level as much as 10-fold (10) .
IL-16 binds to the CD4 receptor and is therefore selectively active on CD4 ϩ T lymphocytes, monocytes, and eosinophils (11, 12) . Like other cytokines, IL-16 exerts numerous and partially contradictory effects in vitro. Although it is able to render CD4 ϩ T cells unresponsive to TCR͞CD3 stimuli, it induces the expression of certain activation markers, such as IL-2 receptor subunits (13) . The proliferative response of CD4 ϩ T cells cotreated with IL-16 and IL-2 for long periods is therefore selectively enhanced (14) , suggesting the possible use of IL-16 as an immune therapy to counteract conditions of CD4 ϩ T cell deficiency such as that associated with AIDS. Moreover, IL-16 inhibits the replication of T cell and monocyte tropic HIV strains in vitro (15) (16) (17) . HIV patients receiving anti-retroviral therapy display rapidly increasing IL-16 serum levels, possibly reflecting the recovery of the immune system as a consequence of the reduced viral load (18) .
To learn more about the expression of IL-16, we have determined the genomic organization of the human IL-16 gene, including the structure and function of its promoter. A DNA fragment spanning the nucleotides from Ϫ408 to ϩ88 of the IL-16 gene was found to exert constitutive promoter activity in lymphoid and nonlymphoid cells. A strong inducible promoter activity in T cells was identified within the immediate 5Ј upstream DNA of approximately 90 bp. Although this promoter fragment lacks any TATA box-like sequence element, it contains three binding sites for Ets-like proteins. One of these fragments overlaps with the previously reported transcriptional start sites (4), whereas the other two sites generate a dyad symmetry element (DSE). We show here that these sites are bound by GA-binding protein (GABP) factors which, in concert with the coactivators CREB binding protein (CBP)͞p300, appear to play an important role in the control of the IL-16 promoter. CBP͞p300 binds to GABP␣ and enhances strongly the GABP mediated IL-16 promoter induction.
was cotransfected and assays were performed by using the Great EscAPe SEAP chemiluminescence detection kit (CLONTECH).
Recombinant DNA Work and Sequence Analysis. Overlapping human IL-16 gene fragments were amplified by using human PBMC DNA, the Tth-Polymerase Mix (CLONTECH), and the following primer pairs: (5Ј-CTGCTGCTACCACAG-GAAGACACAGCAG-3Ј and 5Ј-GAGCTGATTCTCTGC-CTGATGGA-3Ј; 5Ј-GAGCACCTAGGATCACACATC-3Ј  and 5Ј-CTGACCAGACTGAAGGGAACTGTGGTC-3Ј; 5Ј-CAGAGCTGAGAGAATATACAGAGGGTC-3Ј and 5Ј-TTCTAGATCTGCTCCTCCTGCCAAGCT-3Ј; 5Ј-CATGT-CACCATCTTACACAAGGAG-3Ј and 5Ј-CATCACTGGC-TGCAGAGGCTGAGGCTGCAG-3Ј; 5Ј-CACAGAGTGTT-TCCA A ATGGGCTGGCC-3Ј and 5Ј-AGCTGTGTGT-GTTATTGGCTTTGGCTTC-3Ј; 5Ј-ACCACAGCTGCTG-GAGACTCCTAG-3Ј and 5Ј-GTGGTAAGTAGTAGCAAT-TTTATTTGATAC-3Ј) The amplification products were cloned in the pGEM-T-vector (Promega) and sequenced. To minimize sequencing errors, multiple clones were sequenced for every fragment.
For the cloning of the chromosomal DNA upstream of the human IL-16 cDNA-sequence two cDNA based reversecomplementary primers, hGSP1: 5Ј-TCTTCTCCACCCTG-GCTCGCCCTCTGT-3Ј and hGSP2: 5Ј-ACTTGGTCTGT-GGGCCGATACCAGGT-3Ј, were used in a nested PCR with parts of the human PromoterFinder DNA Walking kit (CLONTECH) according to the manufacturer's protocol. Fragments of 1.7 kb (DraI library) and 1.9 kb (PvuII library) were amplified and cloned in pGEM-T. Sequencing revealed the expected 62 bp of the 5Ј end of the IL-16 cDNA sequence (4) upstream of the GSP2 binding site, proving the specificity of the PCRs. In the same way, by using the murine IL-16 cDNA-specific reverse-complementary primers mGSP1: 5Ј-GGCACTCCTCCTTGACTCTCCTTCTGA-3Ј and mGSP2: 5Ј-TGAAGTCTGCGTGCTGGCTGCAGGTC-3Ј along with the murine PromoterFinder DNA Walking kit (CLONTECH), a 1.2-kb genomic fragment (SspI-library) containing the sequence upstream of the known cDNA (19) and 52 bp of its 5Ј-end was amplified.
For the construction of the promoter͞reporter gene plasmids the genomic fragment from Ϫ1048 to ϩ88 was amplified by using primers P1: 5Ј-CTACAGGGTACCTGGAAG-GAAGCCTGCAGCCATGTC-3Ј, and P2: 5Ј-TTCAGT-TATCTCGAGCTTGGTCTGTGGGGCGATACCAGGT-3Ј and human DNA from PBMCs as template. The PCR product was cloned into the pGL3-Basic vector (Promega) and sequenced. Using this plasmid as template, the subfragments Ϫ408͞ϩ88, Ϫ133͞ϩ88, Ϫ90͞ϩ88, Ϫ408͞ϩ3, Ϫ408͞Ϫ110 were amplified and cloned in pGL-3-Basic. All clonings were verified by sequencing.
GG-to-CC changes within the ERE (Ets-related element)-C and -D motifs and the ϩ12 GABP-binding site were introduced into the Ϫ408͞ϩ88 promoter fragment by using the QuikChange site-directed mutagenesis system (Stratagene).
Electrophoretic Mobility-Shift Assays (EMSAs). EMSAs were performed as described (20) by using 2 g of nuclear protein and 0.5 g of poly(dI-dC). In supershift EMSAs, 1 g of antibodies (Abs) raised against GABP␣, ␤ (21) or PU.1 (20) were added to the incubations. When the DNA binding of recombinant GABP was tested, 2.5-20 ng of bacterially expressed proteins prepared as described (21) were incubated in EMSAs.
Interaction Between GABPs and p300. Five micrograms of bacterially expressed GST͞p300 fusion proteins was immobilized on glutathione agarose beads (30 l) and incubated with 50 ng of bacterially expressed full-size GABP␣, -␤ or -␣ϩ␤ (21) in 500 l of binding buffer (20 mM Tris⅐Cl, pH 7.8͞75 mM NaCl͞0.5 mM EDTA͞0.5 mM EGTA͞5 mM NaF͞0.5 mM DTT͞20 M leupeptin͞0.2 mM AMSF͞0.5% nonfat dry milk as blocker). After rotating for 2 h at 4°C and extensive washings with the binding buffer, bound proteins were eluted by boiling in Laemmli sample buffer, fractionated on a 12.5% polyacrylamide gel, and immunodetected by using GABP␣ϩ␤-specific Abs.
RESULTS
Organization of the Human IL-16 Gene. For the analysis of the chromosomal IL-16 gene, overlapping genomic DNA fragments from human PBMCs were amplified by using IL-16 cDNA-specific primer pairs and sequenced. The human IL-16 gene spans approximately 12.8 kb and consists of seven exons and six introns (Fig. 1) . Exon I contains the largest part of the 5Ј-untranslated mRNA region. The first ATG, which corresponds to the translational start codon (4), starts on nucleotide position 51 of exon II. This exon is unusually long (1096 bp), encoding 348 aa harboring the proline-rich part and the N-terminal region of the first PDZ domain (19) . Exon III and the first nucleotides of exon IV code for the remainder of the first PDZ domain. PDZ-2 is encoded by the exons IV and V. Exons VI and VII contain the sequence for PDZ-3 (found in mature IL-16). The cleavage site for the putative processing enzyme caspase 3 is encoded in exon V.
Characterization of the IL-16 Promoter. Fig. 2 shows a sequence comparison between the 5Ј-flanking regions of human and murine IL-16 genes spanning the nucleotides from position Ϫ440 to ϩ130. The 5Ј-untranslated mRNA regions and the immediate upstream regions (up to Ϫ120) from both genes share a high sequence homology, suggesting their functional importance. Multiple transcriptional initiation sites have been identified within 40 bp 5Ј of the murine and human IL-16 genes (4, 19) from which the most upstream site of human IL-16 gene was assigned to be position ϩ1 (4). Accordingly, neither the human nor murine IL-16 gene contains a canonical TATA box. CAAT box motifs are present at the positions Ϫ98 and Ϫ118, and at ϩ12, Ϫ25, and Ϫ39 of both genes three sites are located for the putative binding of Ets-like transcription factors. The Ets elements at ϩ12 and Ϫ25 of the human gene form a direct repeat of 11 bp, whereas in both genes those repeats around Ϫ25 and Ϫ39 are part of a 33 bp-inverted repeat. A very similar repeat designated as DSE was recently identified as an inducible sequence element of a distal IL-2 enhancer (20) .
To test the IL-16 promoter activity, a DNA fragment from position Ϫ1048 to ϩ88 and shorter subfragments were cloned in front of a luciferase reporter gene and transiently trans- . This splice acceptor is predominantly used in mice because we were unable to find cDNAs encoding this alanine in murine PBMCs (19 Fig. 3A , the fragments Ϫ1048͞ϩ88 and Ϫ408͞ϩ88 exhibited a distinct promoter activity in both types of cells, being 4-to 5-fold stronger in Jurkat cells than in HeLa cells. Deletion of 5Ј nucleotides up to the CAAT box-like motifs (up to Ϫ133) resulted in a 50% decrease and the removal of this motifs by deletion up to Ϫ90 in a further strong decrease of constitutive promoter activity. A similar strong decrease was observed after deleting the 3Ј region between positions ϩ3 and ϩ88 containing the Ets element at ϩ12, and the removal of sequences between Ϫ110 and ϩ88 abolished any promoter activity.
To delineate the inducible promoter elements, transfected Jurkat cells and HeLa cells were induced with phorbol ester for 20 h. This resulted in a 7-to 8-fold increase of luciferase reporter gene expression in Jurkat cells, but not in HeLa cells transfected with constructs containing the IL-16 promoter region from Ϫ90 to ϩ88 (Fig. 3B) . Deletion of the sequences from ϩ4 to ϩ88, which include the third Ets-like protein binding site at ϩ12 decreased the inducibility up to 50%. Because removal of the upstream region from position Ϫ1048 to Ϫ90 did not change the inducibility, the fragment from position Ϫ90 to ϩ88 appears to harbor all sequence motifs for the induction of the IL-16 promoter in T cells.
The Binding of GABP␣ and -␤ to the Ets-Binding Sites of Proximal Promoter Region Contributes to the IL-16 Promoter Induction. The DSE of the distal IL-2 enhancer (DSE IL-2 ) is bound by GABP factors (20) , suggesting a binding of these factors to the IL-16 DSE (DSE IL-16 ) as well. To test this assumption, nuclear proteins from Jurkat cells were incubated in EMSAs by using the DSEs from the IL-16 promoter and distal IL-2 enhancer as probes. Very similar to the DSE IL-2 , four specific protein-DNA complexes were generated with the DSE IL-16 which we designate as I (a and b, higher and lower, respectively), II, and III (Fig. 4A) . TPA treatment of cells did not alter their appearance (data not shown). The formation of all four complexes was abolished by a 100-and 200-fold molar excess of the unlabeled probe or a similar excess of the ERE-A site from the DSE IL-2 ( Fig. 4B ) and the SV40 enhancer Ets site, a known GABP-binding site (20) and the ϩ12 Ets-like site (see Fig. 4A, lanes 3ϩ4, 7ϩ8, 9ϩ10, and 15ϩ16 ). The competition with the ϩ12 site indicates that this site is an additional GABP-binding site. No competition was observed when the same excess was used of a DSE IL-16 mutated in both Ets motifs (Fig. 4A, lanes 5ϩ6) or of binding sites for NF-AT, AP-1 and NF-B factors (Fig. 4A, lanes 11-14, 17ϩ18) . To identify the GABP proteins in the IL-16 DSE complexes, EMSA supershift assays were performed by using Abs raised against GABP␣ and -␤. As shown in Fig. 4C (lanes 1-4) , addition of these Abs resulted in the generation of several ''supershift complexes'' at the expense of complexes I and II. No changes in complex formation were observed when an Ab raised against Pu.1, another factor of Ets family (Fig. 4C , lane 5) was used. To confirm these results showing GABP proteins in the DSE complexes, increasing concentrations of bacterially expressed recombinant GABP␣ and -␤ proteins were incubated in EMSAs with a DSE probe. This resulted in the generation of three retarded DNA-protein complexes (Fig.  4D) with identical mobilities to those of complexes Ia, II, and III. Whereas the rapidly running complex III was generated with GABP␣ alone, for the generation of complexes Ia and II, the presence of both GABP␣ and -␤ was necessary indicating the presence of both GABP proteins in complexes I and II.
To demonstrate a functional role for GABP␣ and -␤ in the induction of IL-16 promoter, we transfected a luciferase reporter gene controlled by the IL-16 promoter (from Ϫ408 to ϩ88) into Jurkat and 293 cells alone or with vectors expressing GABP␣ and -␤. As shown in Fig. 5A , both GABP proteins alone exerted a moderate stimulatory effect on both the constitutive and TPA-induced promoter activity, which was significantly enhanced when both proteins were expressed Interaction between GABP␣ and p300. Equal amounts of bacterially expressed glutathione S-transferase͞p300 fusion proteins spanning N-terminal, middle, or C-terminal portions of p300 immobilized on glutathione agrose beads were incubated with 500 ng of bacterially expressed GABP␣, -␤ or -␣ϩ␤. The bound proteins were eluted and immunodetected by using a mix of GABP␣ϩ␤-specific Abs. As a control for p300͞GABP interaction, a glutathione S-transferase fusion protein containing the N-terminal transacting domain of NF-ATc (TADNF-ATc, 113-205) was used. In lane 13, 50 g of nuclear proteins from 293 cells were fractionated. The appearance of a weak GABP␣ band in lane 11 is the result of an accidental contamination of the GABP␤ protein preparation with GABP␣. The appearance of a second GABP␣ band in many lanes is probably a GABP␣ cleavage product. The lowest strong band is most likely the result of the crossreactivity of GABP Abs with a bacterial protein binding unspecifically to p300. together. Mutations in the GABP sites ERE-C and -D (Fig.  4B) , which abolished any GABP binding (Fig. 4A, lanes 5ϩ6 ) reduced significantly the stimulatory effect of GABP proteins on the constitutive and inducible activity of IL-16 promoter (Fig. 5B, CmDm) . Mutation of the ϩ12 GABP site, alone or together with the CmDm mutations, suppressed any promoter induction (Fig. 5B , INIm and CmDmϩINIm), indicating a critical role for this site in the control of promoter activity. The Cofactors CBP͞p300 Bind to GABP Proteins and Enhance the Induction of IL-16 Promoter. Ets-1, the prototype of Ets factors, was shown to cooperate with the nuclear coactivators CBP͞p300 (23, 24) . To investigate whether CBP͞ p300 plays a similar role in the activation of IL-16 promoter by GABP factors, increasing amounts of vectors expressing p300 or CBP were cotransfected into 293 cells with the luciferase reporter gene controlled by the IL-16 promoter. Overexpressing p300 (Fig. 5C ) or CBP (data not shown) resulted in a dose-dependent increase in the constitutive and inducible IL-16 promoter activity, suggesting that this cofactor participates in the activation of the IL-16 promoter. To demonstrate that the GABP factors are the targets of p300-mediated activation of the IL-16 promoter, binding of p300 to GABP proteins was tested. Bacterially expressed, full-length GABP␣ and -␤ were incubated with GST͞p300 proteins spanning large portions of the N-terminal, central, and C-terminal regions of p300. As shown in Fig. 5D , GABP␣ bound specifically to the C-terminal part of p300 and much more weakly to its Nterminal part. No binding to the N-terminal transactivation domain of NF-ATc (TAD-NFATc) used as negative control was observed. GABP␤ was only found in the GST͞p300-bound fraction when incubated together with GABP␣ (Fig. 5D, lane  12) , indicating an indirect, GABP␣-mediated recruitment of GABP␤. These results demonstrate a direct interaction between GABP␣ and the C-terminal part of p300.
DISCUSSION
In this study we have described the structure of the human IL-16 gene, including its promoter. The IL-16 gene consists of seven exons. Exons II-VII encode the pro-IL-16 precursor protein, whereas the mature IL-16 is encoded by sequences of the last three exons. The IL-16 gene is almost exclusively expressed in lymphocytes and epidermis cells of the respiratory tract after allergic stimulation (4, 25, 26) . It has been shown that the activation of lymphocytes by antigens, PHA, and other mitogens strongly increases the transcription of IL-16 (1, 10) . We have identified the immediate upstream region of the IL-16 gene (reaching up to nucleotide position Ϫ90), along with the first 88 bp of the untranslated mRNA region, as the most important DNA fragment for the control of inducible expression of IL-16 gene in T lymphocytes. This region contains three GGAA core motifs for the binding of Ets-like factors around the positions Ϫ39, Ϫ25, and ϩ12. The two upstream sites at Ϫ39 and Ϫ25 form a 33-bp DSE that resembles the DSE motifs within a distal IL-2 enhancer (see Fig. 4B ) and the CD18 promoter. As shown previously for GABP binding to the DSE of the distal IL-2 enhancer (20) the GABP proteins ␣ and ␤ are the most prominent factors binding to the DSE of IL-16 promoter in nuclear protein extracts from T cells. Because the introduction of mutations into these GABP binding sites (Fig. 4B ) reduced significantly the induction of promoter in Jurkat cells (Fig. 5A) , one has to conclude that the binding of GABP factors to both sites is of crucial importance for the induction of IL-16 promoter in T cells.
GABP␣ and -␤ form heterodimeric (␣-␤) and heterotetrameric (␣ 2 -␤ 2 ) complexes when they bind to the DSE of the distal IL-2 enhancer (20, 21). The same heteromeric complexes were generated with the DSE IL-16 as probe (Fig. 4 A and D) . However, approximately 3-fold more tetrameric than dimeric complexes were formed on the DSE IL-16 than DSE IL-2 (determined by dividing the amount of tetrameric complexes by that of dimeric complexes according to phosphoimager data, see also lanes 1 and 2 in Fig. 4A ). This may be caused by the specific structure of DSE , in which the GGAA core sequences, although forming a palindrome (as in the DSE IL-2 ) are not directed to each other (as in the DSE IL-2 ) but are directed in opposite directions. This configuration appears to facilitate the formation of heterotetramers, probably through the leucine zipper motifs in GABP␤ (see refs. 27 and 28 for a discussion) and appears to enhance transcription. We have shown previously for the activity of multiples of DSE IL-2 that the generation of heterotetramers gives rise to a strong activation of transcription compared with the relatively weak activity of multiple repeats of identical EREs to which GABP␣ and -␤ bind as heterodimers (20) .
The transcriptional induction of IL-16 promoter by GABP factors is distinctly enhanced by the cofactors CBP͞p300, which interact with GABP␣ (Fig. 5D ). CBP and p300 are nuclear proteins that were shown to bind to and to increase the activity of numerous transcription factors by exerting adaptor functions and histone acetylase activity (29) . Moreover, they provide a molecular platform for a large number of potentially important associated proteins (30) . Interestingly, several inducible transcription factors, such as AP-1͞c-Jun, NF-kB͞p65, and the NF-AT factors NF-ATp and c, that are activated after lymphocyte activation, were shown to cooperate with CBP͞ p300 (31, 32) . For NF-ATc, it has been demonstrated that CBP͞p300 is able to synergize with multiple protein kinase cascades in the transcriptional activation of this factor. This may also be true for the activation of GABPs that are a nuclear target of Ras-Raf-Erk and JNK͞SAP kinase cascades (21, 33) . Although a direct phosphorylation of GABP␣ by Erk2 has been demonstrated in vitro and in vivo (33) , the phosphorylation of CBP͞p300 or of associated proteins by these mitogenactivated protein kinases provides a further level of regulation through which the induction of IL-16 promoter by GABP factors may be controlled in T cells.
The third Ets-like binding site at position ϩ12 appears to be a further GABP-binding site. Deletion of the region containing this site decreased both the constitutive and inducible activation of IL-16 promoter (see Fig. 3A ). Many TATA-less RNA polymerase II promoters contain typical initiator elements, i.e., short conserved sequences that are bound by proteins of the transcriptional machinery. Some of these promoters, including the CD3, CD4, CD11c, CD18, CD72, IL-2R␤, TGF␤ RII, Ets-2, murine laminin B2, type IV collagenase, thymidylate synthetase, and cytochrome c oxidase subunit IV promoters possess Ets-like binding motifs near their transcriptional start sites, suggesting a new class of initiator elements (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . Recently, two PEA3 motifs that are bound by GABP factors were shown to function as a minimal transcriptional initiator element when placed in front of a luciferase gene (46) . Thus, the ϩ12 GABP binding site of IL-16 promoter might act as a similar initiator element starting transcription from the TATA-less IL-16 gene.
The CAAT box-like sequences located between Ϫ133 and Ϫ90 are needed for the full IL-16 promoter activity in both Jurkat T cells and HeLa cells. Additional positively acting sequence element(s) is͞are located in the region between Ϫ408 and Ϫ133, because deletion of this segment leads to a 50% decrease of promoter activity. However, the sequence elements and the transcription factors binding to and controlling the activity of these elements remain to be identified.
Taken together, the structure of the inducible IL-16 promoter differs markedly from that of typical interleukin promoters (such as the IL-2 and IL-4 promoters), which are predominantly activated on antigen-mediated stimulation in peripheral CD4 ϩ T cells. It will be interesting to determine the Immunology: Bannert et al.
Proc. Natl. Acad. Sci. USA 96 (1999) physiological differences reflected in the architecture of these two types of lymphokine promoters.
